These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31028364)

  • 1. Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified.
    Laginestra MA; Cascione L; Motta G; Fuligni F; Agostinelli C; Rossi M; Sapienza MR; Righi S; Broccoli A; Indio V; Melle F; Tabanelli V; Calleri A; Novero D; Facchetti F; Inghirami G; Sabattini E; Bertoni F; Pileri SA
    Mod Pathol; 2020 Feb; 33(2):179-187. PubMed ID: 31028364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TP53 and KMT2D mutations associated with worse prognosis in peripheral T-cell lymphomas.
    Wang L; Yang L; Guan F; Chen J; Cheng Y; Miao Y; He J; Cai Z; Huang H; Zhao Y
    Cancer Med; 2024 Jul; 13(14):e70027. PubMed ID: 39041683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling.
    Watatani Y; Sato Y; Miyoshi H; Sakamoto K; Nishida K; Gion Y; Nagata Y; Shiraishi Y; Chiba K; Tanaka H; Zhao L; Ochi Y; Takeuchi Y; Takeda J; Ueno H; Kogure Y; Shiozawa Y; Kakiuchi N; Yoshizato T; Nakagawa MM; Nanya Y; Yoshida K; Makishima H; Sanada M; Sakata-Yanagimoto M; Chiba S; Matsuoka R; Noguchi M; Hiramoto N; Ishikawa T; Kitagawa J; Nakamura N; Tsurumi H; Miyazaki T; Kito Y; Miyano S; Shimoda K; Takeuchi K; Ohshima K; Yoshino T; Ogawa S; Kataoka K
    Leukemia; 2019 Dec; 33(12):2867-2883. PubMed ID: 31092896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TP53 mutations in peripheral mature T and NK cell lymphomas: a whole-exome sequencing study with correlation to p53 expression.
    Huang HS; Liao CK; Liu TT; You HL; Wang MC; Huang WT
    Hum Pathol; 2018 Oct; 80():145-151. PubMed ID: 29885407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified.
    Ji MM; Huang YH; Huang JY; Wang ZF; Fu D; Liu H; Liu F; Leboeuf C; Wang L; Ye J; Lu YM; Janin A; Cheng S; Zhao WL
    Haematologica; 2018 Apr; 103(4):679-687. PubMed ID: 29305415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas.
    Palomero T; Couronné L; Khiabanian H; Kim MY; Ambesi-Impiombato A; Perez-Garcia A; Carpenter Z; Abate F; Allegretta M; Haydu JE; Jiang X; Lossos IS; Nicolas C; Balbin M; Bastard C; Bhagat G; Piris MA; Campo E; Bernard OA; Rabadan R; Ferrando AA
    Nat Genet; 2014 Feb; 46(2):166-70. PubMed ID: 24413734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathological features of angioimmunoblastic T-cell lymphomas with IDH2
    Steinhilber J; Mederake M; Bonzheim I; Serinsöz-Linke E; Müller I; Fallier-Becker P; Lemonnier F; Gaulard P; Fend F; Quintanilla-Martinez L
    Mod Pathol; 2019 Jul; 32(8):1123-1134. PubMed ID: 30952970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction: Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified.
    Laginestra MA; Cascione L; Motta G; Fuligni F; Agostinelli C; Rossi M; Sapienza MR; Righi S; Broccoli A; Indio V; Melle F; Tabanelli V; Calleri A; Novero D; Facchetti F; Inghirami G; Sabattini E; Bertoni F; Pileri SA
    Mod Pathol; 2020 Feb; 33(2):319. PubMed ID: 31558781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations.
    Neumann M; Heesch S; Schlee C; Schwartz S; Gökbuget N; Hoelzer D; Konstandin NP; Ksienzyk B; Vosberg S; Graf A; Krebs S; Blum H; Raff T; Brüggemann M; Hofmann WK; Hecht J; Bohlander SK; Greif PA; Baldus CD
    Blood; 2013 Jun; 121(23):4749-52. PubMed ID: 23603912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput Sequencing of Subcutaneous Panniculitis-like T-Cell Lymphoma Reveals Candidate Pathogenic Mutations.
    Fernandez-Pol S; Costa HA; Steiner DF; Ma L; Merker JD; Kim YH; Arber DA; Kim J
    Appl Immunohistochem Mol Morphol; 2019; 27(10):740-748. PubMed ID: 31702703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma.
    Zhang P; Zhang M
    Clin Epigenetics; 2020 Nov; 12(1):169. PubMed ID: 33160401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FAT1 somatic mutations in head and neck carcinoma are associated with tumor progression and survival.
    Lin SC; Lin LH; Yu SY; Kao SY; Chang KW; Cheng HW; Liu CJ
    Carcinogenesis; 2018 Dec; 39(11):1320-1330. PubMed ID: 30102337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Landscape and Classification of Peripheral T Cell Lymphomas.
    Sandell RF; Boddicker RL; Feldman AL
    Curr Oncol Rep; 2017 Apr; 19(4):28. PubMed ID: 28303495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features.
    Bisig B; de Reyniès A; Bonnet C; Sujobert P; Rickman DS; Marafioti T; Delsol G; Lamant L; Gaulard P; de Leval L
    Haematologica; 2013 Aug; 98(8):1250-8. PubMed ID: 23716562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological characterization of follicular helper T-cell-derived peripheral T-cell lymphoma involving Waldeyer's ring.
    Wang J; Tang W; Zhang W; Wang J; Chen F; Zhong L; Chen Y; Chen G
    Virchows Arch; 2021 Aug; 479(2):355-363. PubMed ID: 33650043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent Mutations in APC and CTNNB1 and Activated Wnt/β-catenin Signaling in Intraductal Papillary Neoplasms of the Bile Duct: A Whole Exome Sequencing Study.
    Fujikura K; Akita M; Ajiki T; Fukumoto T; Itoh T; Zen Y
    Am J Surg Pathol; 2018 Dec; 42(12):1674-1685. PubMed ID: 30212390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary CNS T-cell Lymphomas: A Clinical, Morphologic, Immunophenotypic, and Molecular Analysis.
    Menon MP; Nicolae A; Meeker H; Raffeld M; Xi L; Jegalian AG; Miller DC; Pittaluga S; Jaffe ES
    Am J Surg Pathol; 2015 Dec; 39(12):1719-1729. PubMed ID: 26379152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted sequencing to identify genetic alterations and prognostic markers in pediatric T-cell acute lymphoblastic leukemia.
    Chang YH; Yu CH; Jou ST; Lin CY; Lin KH; Lu MY; Wu KH; Chang HH; Lin DT; Lin SW; Chen HY; Yang YL
    Sci Rep; 2021 Jan; 11(1):769. PubMed ID: 33436855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candidate susceptibility variants in angioimmunoblastic T-cell lymphoma.
    Donner I; Katainen R; Kaasinen E; Aavikko M; Sipilä LJ; Pukkala E; Aaltonen LA
    Fam Cancer; 2019 Jan; 18(1):113-119. PubMed ID: 30097855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of genetic alterations of peripheral T-cell lymphoma in childhood including identification of novel fusion genes: the Japan Children's Cancer Group (JCCG).
    Ohki K; Kiyokawa N; Watanabe S; Iwafuchi H; Nakazawa A; Ishiwata K; Ogata-Kawata H; Nakabayashi K; Okamura K; Tanaka F; Fukano R; Hata K; Mori T; Moriya Saito A; Hayashi Y; Taga T; Sekimizu M; Kobayashi R;
    Br J Haematol; 2021 Aug; 194(4):718-729. PubMed ID: 34258755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.